Position in MRNA
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$43,180
+$18,055 QoQ
Shares Held
850
-0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026First Command Advisory Services, Inc. holds $143,852 across 14 Biotechnology names. MRNA ranks #2 (30.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
2,000 | $47,120 | |
| 2 | MRNA |
Moderna, Inc.
This page
|
850 | $43,180 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
81 | $36,169 | |
| 4 | ARGX |
Argenx SE
|
6 | $4,381 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
12 | $3,970 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5 | $3,863 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
90 | $2,928 | |
| 8 | INSM |
INSMED Inc
|
8 | $1,308 |
All Filings in MRNA
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,180 | 850 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $25,125 | 852 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $41,379 | 1,602 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $44,199 | 1,602 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $45,416 | 1,602 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $66,611 | 1,602 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $107,061 | 1,602 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $190,237 | 1,602 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $171,135 | 1,606 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $159,318 | 1,602 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $165,470 | 1,602 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||